In this episode of 'Modern Solutions for Modern Restaurants', hosted by Paul Molinari from Popcorn GTM, we dive into the significant impact GLP-1 medications are having on consumer dining habits. Originally developed for diabetes, these drugs are now revolutionizing weight loss and, consequently, how people engage with restaurants. We discuss how these medications are driving a shift toward smaller portions, higher protein content, and nutrient-dense options. Paul highlights real-world examples from chains like Chipotle, Shake Shack, and Smoothie King, and offers insights into menu design, portion economics, and strategic marketing adjustments. Tune in to learn how to adapt your restaurant's strategy to meet these evolving consumer needs.